Staar Surgical price target lowered to $17 from $28 at Canaccord

Canaccord lowered the firm’s price target on Staar Surgical (STAA) to $17 from $28 and keeps a Hold rating on the shares. The firm updated its estimates following its Q4 results and they believe the quarter was a clearing event for the company. Canacccord said while they are warming up to the stock at these valuations, they remain on the sidelines until they see at least stabilization in the China market, and global demand for refractive surgery to at least stabilize.